The methylation of CCND2 promoter was also detected in ductal carcinoma in situ, which suggested that loss of CCND2 is an early event in tumorigenesis and may associated with the evolution of breast cancer [6]. Here, CCND2 is linked to ductal breast carcinoma in situ.